Boc-L-beta-homomethionine is a non-natural, protected amino acid derivative. Its chemical structure features a beta-homomethionine backbone, where the amino group is protected by a tert-butoxycarbonyl (Boc) group, and the side chain contains a methylthio (-S-CH3) moiety. This specific configuration makes it a chiral building block with an extended carbon chain compared to standard methionine. This compound is primarily employed as a key synthetic intermediate in pharmaceutical research and development. It serves as a crucial building block for the solid-phase peptide synthesis (SPPS) of peptide-based drug candidates and for constructing peptidomimetics. The Boc protecting group is orthogonal to Fmoc strategies and can be removed under acidic conditions, allowing for flexible synthetic routes. Its application is particularly relevant in creating novel therapeutic peptides where the incorporation of a sulfur-containing, non-natural amino acid can modulate biological activity, stability, or pharmacokinetic properties. As a specialized, protected amino acid, it is not a commodity chemical but a high-value research reagent. Its use is confined to laboratory-scale synthesis for drug discovery purposes. Proper handling requires standard precautions for laboratory chemicals, including avoiding inhalation and contact with skin or eyes.